Tenecteplase - CSPC Recomgen Pharmaceutical
Alternative Names: Mingfule; Recombinant Human TNK Tissue-type Plasminogen Activator; Recomlyse; Reflow; rhTNK-tPALatest Information Update: 14 Mar 2023
At a glance
- Originator CSPC Recomgen Pharmaceutical (Guangzhou)
- Class Blood coagulation factors; Plasminogen activator enzymes; Serine endopeptidases; Thrombolytics
- Mechanism of Action Plasminogen activators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Myocardial infarction
- Preregistration Stroke